<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A fatal <z:mp ids='MP_0005048'>thrombosis</z:mp> originating at the junction of an aortic bioprosthetic heart valve and a Dacron aortic graft was observed in a patient with the <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, who had had replacement of the ascending aorta with a valved conduit 29 months previously </plain></SENT>
<SENT sid="1" pm="."><plain>This unique complication raises the question of whether patients with such prostheses should be on a program of full anticoagulation </plain></SENT>
</text></document>